Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof
US9255136B2 · kind B2 · utility
2Cited by
6References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 8, 2011 |
| Grant date | Feb 9, 2016 |
| Priority date | — |
| Expiry date | Apr 8, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Polypeptide The present invention relates to polypeptides fragments derived from the protein TLT-1 have been isolated and are useful in pharmaceutical preparations used for the treatment of inflammatory conditions such as sepsis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.